The Effect of Albumin and Platelet-Poor Plasma Supplemented Botulinum A Toxin on Bioavaliability

Autor: Murat Zinnuroglu, Seyhan Çenetoğlu, Serhat Sibar, Kemal Findikcioglu

Publikováno v: Annals of Plastic Surgery. 78:436-442

Today, botulinum toxin is commonly used for cosmetic purposes throughout the world. Despite various agents reducing the efficiency of toxin are well defined, the studies related to increasing the bioavailability are limited. The purpose of our study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186d8242a534fdf9fc3ab20c5759becd
https://doi.org/10.1097/sap.0000000000000957

Thematic stream: inflammatory arthritis (PP01-PP31): PP01. Autoinflammatory Synovitis in Familial Mediterranean Fever is Characterized by Numerous Neutrophils Lacking Myeloperoxidase and Lysozyme, Macrophages, Mast Cells and B Cells, Up-Regulation of Galectin-1, P65 (REL A)/NF-KB and Inos, but not COX-2

Autor: James Cheng-Chung Wei, Tugba Baysak, Aysegul Kucukali Turkyilmaz, Hisashi Yamanaka, Izzet Fresko, Metin Ozgen, Moots Robert, Bunyamin Kisacik, Won Park, Yoshiya Tanaka, Ibrahim Batmaz, Özer Arıcan, Aytul Cakci, Serdar Budak, Jisoo Lee, Kouichi Amano, Rezzan Günaydin, Hatice Bodur, Sema Yilmaz, Yasin Tuluce, Bonnie Vlahos, Derya Kaskari, Tastekin Ebru, Ömür Kayıkçı, Suleyman Yildirim, Chun-Huang Huang, Inita Bulina, Mehmet Tosun, Erten Surkan, Johan Rönnelid, Walter Conca, Ayşegül Koç, Akın Erdal, Vıldan Altunayoğlu Çakmak, Ayhan Dinc, Ajda Bal, Mohammed Mullazehi, Hasan Battal, Sibel Süzen, Sun-Won Park, Daina Andersone, Li-Jie Shiu, Murat Toprak, Gülsüm Emel Pamuk, Çiftdemir Mert, Hyo Jin Choi, Tuba Baykal, Hideto Kameda, Josef S. Smolen, Alif Adlan Mohd Thabit, Masao Nawata, Mehmet Karakoç, Ozcan Hiz, Gulen Hatemi, Chan Hee Lee, Murat Zinnuroglu, Halil Koyuncu, Pierre Tane, Peter Nash, Tsutomu Takeuchi, Mehmet I. Arman, Shunsuke Fukuyo, Filiz Alp, Heselynn Hussein, Zuhal Atılgan, Murat Uludağ, Aylin Rezvani, Huri Ozdogan, Halil Ozkol, Ekin Sen, Yuko Kaneko, Seung Jae Hong, Ji Young Hwang, Constance Hammond, Kılınç Serdar, Eri Satoh, Chang-Hee Suh, Altinay Goksel Karatepe, Umut Kalyoncu, Daisuke Hoshi, Albert Kamanyi, Engin Tezcan, Inta Jaunalksne, Blanche Laure Ndontsa, Hong-Shen Lee, Hui Jen Ding, Mahir Ugur, Marius Mbiantcha, Zeynep Erden, Feride Gogus, Sebahattin Yurdakul, Haner Direskeneli, Altunoglu Alpaslan, Omer Karadag, Sina Esmaeilzadeh, Ruey-Hong Wong, Andrew S Koenig, Pedro Miranda, Bruce Freundlich, Taciser Kaya, Sedat Kiraz, You-Hyun Lee, Şafak Karamehmetoğlu, Ahmet Kiziltunc, Hayato Nagasawa, Erhan Capkin, Takahiko Kurasawa, Nurettin İrem Örnek, Aysegul Jale Saraç, Karel Pavelka, De Silva Vijitha, Deniz Dulgeroglu, Necati Çakır, Emel Ozcan, Remzi Çevik, alternative medicines, Erten Serhat Fuat, Kazim Senel, Ihsan Ertenli, Macfarlane Gary, Omer Nuri Pamuk, Levent Ediz, Salim Dönmez, Tugba Yalcin, El-Metwally Ashraf, Sedat Yilmaz, Suhail Al-Salam, Kentaro Hanami, Heidi Kokkonen, Kerem Gün, Solbritt Rantapää-Dahlqvist, Usta Ufuk, Kemal Nas, Selma Yazıcı, Muammer Muslım Kose, Fatih Baygutalp, Elif Gulcu, Kazuyoshi Saito, Murat Karkucak, Tastekin Nurettin, Ronald Pedersen, Birtane Murat, Telesphore Benoit Nguelefack

Publikováno v: Rheumatology. 50:ii6-ii14

Background: Recent recommendations have established clinical remission ideally or low disease activity (LDA) as therapeutic targets in all patients with rheumatoid arthritis (RA). Controlled studies of biologic agents have primarily assessed treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa7a9816ff3e1405aad7e80d5c280f44
https://doi.org/10.1093/rheumatology/ker097